Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570284 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors
A Phase 1 study of Cancer, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 9
- Study locations
NCT00570284: Completed Phase 1 study of Cancer, sponsored by Novartis Pharmaceuticals.
NCT00570284 is a Phase 1 study of Cancer that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 36 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00570284, a Phase 1 study of Cancer, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 9
- Study locations
Study Summary
The primary purpose of this study is to evaluate the effect of food on oral LBH589 in adult patients with advanced solid tumors. This study will also evaluate the safety and efficacy of LBH589 in adult patients with advanced solid tumors
Conditions Studied
Interventions
- DRUG LBH589
Study Locations (9)
Other
- Novartis Investigative Site - Stockholm
- Novartis Investigative Site - Zurich
California
- Novartis Investigative Site - Los Angeles
Connecticut
- Novartis Investigative Site - Norwalk
Maryland
- Novartis Investigative Site - Rockville
Massachusetts
- Novartis Investigative Site - Boston
New Hampshire
- Novartis Investigative Site - Lebanon
New York
- Novartis Investigative Site - New York
Wisconsin
- Novartis Investigative Site - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-02 |
| Phase | Phase 1 |
What the finished NCT00570284 record still lists
NCT00570284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which LBH589 is the first listed.
NCT00570284 lists 9 locations in 8 states (Other, California, Connecticut).
Frequently Asked Questions
What is clinical trial NCT00570284 about?
NCT00570284 is a clinical study titled "A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors". The primary purpose of this study is to evaluate the effect of food on oral LBH589 in adult patients with advanced solid tumors. This study will also evaluate the safety and efficacy of LBH589 in adult patients with advanced solid tumors
What is the current status of trial NCT00570284?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2007-11. Estimated completion is 2011-02.
What conditions does trial NCT00570284 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT00570284?
The interventions under investigation include: LBH589 (DRUG).
Who is sponsoring clinical trial NCT00570284?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00570284 being conducted?
This trial has 9 study locations across California, Connecticut, Maryland, Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00570284's enrollment target sits among peer trials
36 485th of 615 higher than 129 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Impact of Daily Oral Cannabis Doses in Patients With Cancer
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia